| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V53100 | 10NH2-11F-Camptothecin | 2873460-30-9 | 10NH2-11F-Camptothecin is an antibody-active molecule conjugate (ADC). |
|
V53102 | 7Ethanol-10NH2-11F-Camptothecin | 2873460-31-0 | 7Ethanol-10NH2-11F-Camptothecin is an antibody-active molecule conjugate (ADC). |
|
V53104 | Azintuxizumab | 1826819-57-1 | Azintuxizumab is an IgG4 bispecific monoclonal antibody (mAb) targeting B-cell maturation antigen (BCMA). |
|
V52323 | Briobacept (BR 3FC) | 869881-54-9 | Briobacept (BR 3FC) is a monoclonal antibody (mAb) that selectively targets BLyS (BAFF) and can induce B cell apoptosis. |
|
V53119 | Cantuzumab | 1204740-23-7 | Cantuzumab is a monoclonal antibody (mAb) that binds to the CanAg antigen. |
|
V53122 | Datopotamab | 2267989-53-5 | Datopotamab (CDP7657) is an antibody targeting TROP2. |
|
V76985 | Gemtuzumab | Gemtuzumab is a monoclonal antibody (mAb) that targets the CD33 antigen, which is present on leukemic myeloblasts in acute myeloid leukemia (AML). | |
|
V52056 | Glembatumumab | 1020264-78-1 | Glembatumumab is a fully human IgG2 monoclonal antibody (mAb) directed against the extracellular domain of GPNMB expressed in human breast cancer and melanoma. |
|
V53153 | Iladatuzumab (MCDS0593A) | 1906205-76-2 | Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody (mAb). |
|
V53167 | Lifastuzumab | 1615697-16-9 | Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (mAb) (IgG1 type). |
|
V76813 | Lonigutamab (hz208F2-4) | Lonigutamab (hz208F2-4) is a humanized anti-IGF-1R monoclonal antibody (mAb) that may be utilized to prepare antibody-active molecule conjugates (ADC). | |
|
V51848 | Lorvotuzumab (Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab)) | 339306-30-8 | Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody (mAb) that binds CD56 (NCAM1). |
|
V53176 | Lupartumab (BAY 1112623) | 1640971-88-5 | Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody (mAb) that may be utilized to prepare the antibody-active molecule conjugate BAY 1129980. |
|
V53177 | MC-GGFG-AM-(10NH2-11F-Camptothecin) | 2873460-71-8 | MC-GGFG-AM-(10NH2-11F-Camptothecin) is an antibody-active molecule conjugate (ADC). |
|
V53087 | Mecbotamab | 2460400-28-4 | Mecbotamab is a humanized IgG1-κ antibody targeting the AXL receptor tyrosine kinase. |
|
V52439 | Mipasetamab | 2361055-48-1 | Mipasetamab is an IgG1κ antibody targeting AXL, which is a tyrosine kinase receptor, or TAM receptor (TAM Receptor). |
|
V53184 | Mirzotamab | 2229859-11-2 | Mirzotamab is an IgG1κ antibody targeting CD276/B7-H3. |
|
V41136 | Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) | 1622327-39-2 | Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody (mAb) that binds CD37 (TSPAN26). |
|
V53203 | Ozuriftamab | 2460399-44-2 | Ozuriftamab is a naked antibody against human IgG1 kappa tyrosine kinase-like orphan receptor 2 (ROR2) and may be utilized to prepare active antibody conjugate molecules (ADC). |
|
V35225 | Tamrintamab (SC-003 mAb; SC-Mab003; SC34.28ss1) | 2148325-59-9 | Tamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting dipeptidase 3 (DPEP3 or MBD3). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
